| |
| |
|
| Insider
Information: |
Middleton Fred A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
593,164 |
|
|
Indirect Shares
|
7,544,680 |
|
|
| Direct
Value |
$2,792,451 |
|
|
|
Indirect Value
|
$6,330,602 |
|
|
| Total
Shares |
8,137,844 |
|
|
| Total
Value |
$9,123,052 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 0.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CALC |
Calcimedica Ord Shs |
|
– • • |
2024-01-23 |
4 |
B |
$3.70 |
$2,515,080 |
I/I |
679,384 |
30,292 |
0.01 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2023-11-17 |
4 |
B |
$0.96 |
$16,522 |
I/I |
17,295 |
100,000 |
2.1 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2023-11-10 |
4 |
B |
$0.92 |
$2,489 |
I/I |
2,705 |
82,705 |
2.02 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2023-09-25 |
4 |
B |
$0.98 |
$19,636 |
I/I |
20,000 |
80,000 |
2.1 |
% |
|
| CALC |
Calcimedica Ord Shs |
Director |
– • • |
2023-06-09 |
4 |
B |
$5.20 |
$3,713 |
D/D |
714 |
11,714 |
3.84 |
- |
|
| CALC |
Calcimedica Ord Shs |
Director |
– • • |
2023-06-07 |
4 |
B |
$5.20 |
$2,600 |
D/D |
500 |
11,000 |
3.84 |
- |
|
| CALC |
Calcimedica Ord Shs |
Director |
– • • |
2023-06-06 |
4 |
B |
$4.88 |
$2,440 |
D/D |
500 |
10,500 |
3.84 |
- |
|
| CALC |
Calcimedica Ord Shs |
Director |
– • • |
2023-05-19 |
4 |
B |
$2.85 |
$28,500 |
D/D |
10,000 |
10,000 |
3.92 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2023-03-28 |
4 |
B |
$1.21 |
$24,152 |
I/I |
20,000 |
60,000 |
2.1 |
% |
|
| CALC |
Calcimedica Ord Shs |
Director |
– • • |
2023-03-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,648,220 |
8,176 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2022-09-29 |
4 |
B |
$1.86 |
$37,176 |
I/I |
20,000 |
40,000 |
2.1 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2022-05-19 |
4 |
B |
$2.04 |
$40,738 |
I/I |
20,000 |
20,000 |
2.1 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2021-06-28 |
4 |
B |
$7.83 |
$54,419 |
D/D |
6,950 |
207,523 |
2.39 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2021-06-25 |
4 |
B |
$7.78 |
$23,729 |
D/D |
3,050 |
200,573 |
2.39 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2020-03-12 |
4 |
B |
$1.40 |
$69,900 |
D/D |
50,000 |
197,523 |
2.39 |
% |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-11-13 |
4 |
B |
$1.82 |
$54,567 |
D/D |
30,000 |
147,523 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-11-11 |
4 |
B |
$1.66 |
$33,190 |
D/D |
20,000 |
117,523 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-05-10 |
4 |
B |
$2.92 |
$87,678 |
D/D |
30,000 |
97,523 |
2.39 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-12-21 |
4 |
D |
$24.00 |
$2,723,736 |
D/D |
(113,489) |
0 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-12-21 |
4 |
D |
$24.00 |
$97,094,808 |
I/I |
(4,045,617) |
0 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
83,860 |
113,489 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
197,349 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2018-03-02 |
4 |
OE |
$0.28 |
$43,077 |
D/D |
153,846 |
303,528 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-02-28 |
4 |
A |
$4.20 |
$2,100,000 |
I/I |
500,000 |
904,465 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
149,682 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
